Katherine Youmans
Postdoctoral Fellow
Boston University School of Medicine



Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Ash PE, Vanderweyde TE, Youmans KL, Apicco DJ, Wolozin B. Pathological stress granules in Alzheimer''s disease. Brain Res. 2014 Oct 10; 1584:52-8.View Related Profiles. PMID: 25108040; PMCID: PMC4256948; DOI: 10.1016/j.brainres.2014.05.052;.
  2. Dusonchet J, Li H, Guillily M, Liu M, Stafa K, Derada Troletti C, Boon JY, Saha S, Glauser L, Mamais A, Citro A, Youmans KL, Liu L, Schneider BL, Aebischer P, Yue Z, Bandopadhyay R, Glicksman MA, Moore DJ, Collins JJ, Wolozin B. A Parkinson''s disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity. Hum Mol Genet. 2014 Sep 15; 23(18):4887-905.View Related Profiles. PMID: 24794857; PMCID: PMC4140468; DOI: 10.1093/hmg/ddu202;.
  3. Kunzler J, Youmans KL, Yu C, Ladu MJ, Tai LM. APOE modulates the effect of estrogen therapy on Aß accumulation EFAD-Tg mice. Neurosci Lett. 2014 Feb 7; 560:131-6. PMID: 24368217; PMCID: PMC3955876; DOI: 10.1016/j.neulet.2013.12.032;.
  4. Tai LM, Bilousova T, Jungbauer L, Roeske SK, Youmans KL, Yu C, Poon WW, Cornwell LB, Miller CA, Vinters HV, Van Eldik LJ, Fardo DW, Estus S, Bu G, Gylys KH, Ladu MJ. Levels of soluble apolipoprotein E/amyloid-ß (Aß) complex are reduced and oligomeric Aß increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples. J Biol Chem. 2013 Feb 22; 288(8):5914-26. PMID: 23293020; PMCID: PMC3581407.
  5. Youmans KL, Tai LM, Nwabuisi-Heath E, Jungbauer L, Kanekiyo T, Gan M, Kim J, Eimer WA, Estus S, Rebeck GW, Weeber EJ, Bu G, Yu C, Ladu MJ. APOE4-specific changes in Aß accumulation in a new transgenic mouse model of Alzheimer disease. J Biol Chem. 2012 Dec 7; 287(50):41774-86. PMID: 23060451; PMCID: PMC3516726.
  6. Youmans KL, Wolozin B. TDP-43: a new player on the AD field? Exp Neurol. 2012 Sep; 237(1):90-5.View Related Profiles. PMID: 22691390; DOI: 10.1016/j.expneurol.2012.05.018;.
  7. Youmans KL, Tai LM, Kanekiyo T, Stine WB, Michon SC, Nwabuisi-Heath E, Manelli AM, Fu Y, Riordan S, Eimer WA, Binder L, Bu G, Yu C, Hartley DM, LaDu MJ. Intraneuronal Aß detection in 5xFAD mice by a new Aß-specific antibody. Mol Neurodegener. 2012; 7:8. PMID: 22423893; PMCID: PMC3355009.
  8. Tai LM, Youmans KL, Jungbauer L, Yu C, Ladu MJ. Introducing Human APOE into Aß Transgenic Mouse Models. Int J Alzheimers Dis. 2011; 2011:810981. PMID: 22028984; PMCID: PMC3199079.
  9. Youmans KL, Leung S, Zhang J, Maus E, Baysac K, Bu G, Vassar R, Yu C, LaDu MJ. Amyloid-ß42 alters apolipoprotein E solubility in brains of mice with five familial AD mutations. J Neurosci Methods. 2011 Mar 15; 196(1):51-9. PMID: 21219931; PMCID: PMC3049315.
  10. Yu C, Youmans KL, LaDu MJ. Proposed mechanism for lipoprotein remodelling in the brain. Biochim Biophys Acta. 2010 Aug; 1801(8):819-23. PMID: 20470897; PMCID: PMC3253707.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 10 publications over 5 distinct years, with a maximum of 3 publications in 2012

YearPublications
20101
20112
20123
20132
20142
Contact for Mentoring:


72 E. Concord St Instructional (L)
Boston MA 02118
Google Map


Youmans's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_